ProHance is a macrocyclic, nonionic, gadolinium-based magnetic resonance imaging (MRI) contrast agent designed for use in MRI in adults and children over two years of age to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. ProHance is also indicated for use in MRI in adults to visualize lesions in the head and neck.
The future is looking bright for virtual colonoscopy (CTC) after encouraging news came out that the Centers for Medicare ...
June 9, 2008 - Curlin Medical was recently awarded a three-year contract to provide its advanced pain management-local ...
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
The FDA granted tentative approval for Covidien’s Abbreviated New Drug Application (ANDA) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien’s tentatively approved product is a generic of Cardiolite, which is a myocardial perfusion imaging agent used for detecting coronary artery disease.
June 9, 2008 – Electronic health records maker MediNotes Corp. said it added 199 new software agreements with new and ...
The FDA recently approved Covidien’s contrast delivery system with radiofrequency identification (RFID) technology ...
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
The EmpowerMR injector system has multiple features created to cope with the problem of electrical interference in the ...
June 9, 2008 - At the request of its membership, the American College of Physicians (ACP) recently conducted an ...
June 9, 2008 - Siemens Medical Solutions gained FDA 510(k) market clearance for the SOMATOM Definition AS, what is said ...
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
GE received FDA clearance for its new Signa MR750 3.0T scanner that delivers up to 60 percent additional anatomical ...
The ACIST CVi Contrast Delivery System provides one injection system for all cardiac and vascular angiography procedures. The variable-rate ACIST CVi system aims to provide ease of operation for clinicians, while obtaining quality images with less contrast used and delivered to the patient.
With radiologists in short supply, the need for teleradiology services continues to grow and the market has responded in ...
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
June 9, 2008 - The administration of imprecise dosages, particularly to small children, remains a serious problem faced ...
The FDA cleared GE Healthcare’s new LightSpeed CT750 HD, a high-definition CT scanner that is said to produce images 100 ...
The Codonics Virtua Medical Disc Publisher is designed to set a new standard for speed, efficiency and ease of use in ...
June 9, 2008 - The FDA cleared Mindray’s DC-3 color ultrasound imaging system, equipped with extensive applications in ...
iCAD’s SecondLook Digital Computer-Aided Detection system for mammography received FDA clearance for sale with FUJIFILM ...
Bayer HealthCare Pharmaceuticals collaborated with Mobile Aspects to create VistaTrak, a touchscreen contrast media ...
June 9, 2008 – American TeleCare Inc. (ATI) released Quick Notes as a new feature of its inLife/LifeView Telehealth ...
June 9, 2008 - Hologic Inc. said today that it has signed a definitive agreement to acquire Third Wave Technologies Inc ...
June 08, 2008 